SCHEMBL7230707

SCHEMBL7230707

N#Cc1cc(NN[SnH])ccc1F

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.41
BLM P54132 1/20 0.38
WRN Q14191 1/20 0.38
TRPV4 Q9HBA0 2/20 0.37
PGR P06401 2/20 0.36
BUB1 O43683 1/20 0.34
AR P10275 2/20 0.34
KCNH2 Q12809 1/20 0.33
ACLY P53396 1/20 0.33
CNR2 P34972 1/20 0.33
EGFR P00533 2/20 0.32
AKT1 P31749 1/20 0.32
PTP4A3 O75365 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21919186 0.81 GRM4 (0.44) GRM4ABCG2BLMWRNTRPV4
SCHEMBL3173181 0.79 GRM4 (0.48) GRM4ABCG2BLMWRNTRPV4
SCHEMBL19190440 0.77 GRM4 (0.50) GRM4ABCG2BLMWRNTRPV4
SCHEMBL21844923 0.77 GRM4 (0.47) GRM4ABCG2BLMWRNTRPV4
SCHEMBL897882 0.77 GRM4 (0.47) GRM4ABCG2BLMWRNTRPV4
Hydrochloric Acid SCHEMBL1765566 0.76 GRM4 (0.46) GRM4ABCG2BLMWRNTRPV4
SCHEMBL7230699 0.76 GRM4 (0.46) GRM4ABCG2BLMWRNTRPV4
Hydrochloric Acid SCHEMBL3829463 0.74 GRM4 (0.48) GRM4ABCG2BLMWRNTRPV4
Hydrochloric Acid SCHEMBL7475755 0.74 GRM4 (0.48) GRM4ABCG2BLMWRNTRPV4
SCHEMBL14730465 0.74 GRM4 (0.48) GRM4ABCG2BLMWRNTRPV4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6548512-B1 Pyrazole derivatives such as 1-(3-amidinophenyl)-3-methyl-2-((5-(2'-aminosulfonylphenyl-1-yl)pyrimidin-2 -yl)aminocarbonyl)pyrazole; treating thromboembolic disorders BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-04-15 US disclosed
US-6020357-A CARDIOVASCULAR DISORDERS; ANTCOAGULANTS DUPONT PHARMACEUTICALS COMPANY (US) 2000-02-01 US disclosed